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Although is well accepted that the central nervous system has an immune privilege
protected by the blood–brain barrier (BBB) and maintained by the glia, it is also known that
in homeostatic conditions, peripheral immune cells are able to penetrate to the deepest
regions of brain without altering the structural integrity of the BBB. Nearly all neurological
diseases, including degenerative, autoimmune or infectious ones, compromising brain
functions, develop with a common pattern of inﬂammation in which macrophages and
microglia activation have been regarded often as the “bad guys.” However, recognizing the
huge heterogeneity ofmacrophage populations and also the different expression properties
of microglia, there is increasing evidence of alternative conditions in which these cells,
if primed and addressed in the correct direction, could be essential for reparative and
regenerative functions. The main proposal of this review is to integrate studies about
macrophage’s biology at the brain borders where the ultimate challenge is to penetrate
through the BBB and contribute to change or even stop the course of disease. Thanks to
the efforts made in the last century, this special wall is currently recognized as a highly
regulated cooperative structure, in which their components form neurovascular units. This
new scenario prompted us to review the precise cross-talk between the mind and body
modes of immune response.
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INTRODUCTION
The understanding of immune regulation between the body and
the brain is essential to unravel the molecular basis of many etiolo-
gies affecting the central nervous system (CNS), but despite great
and combined efforts of neuroscience and immunology, there are
still some questions that need additional answers:
Why having the brain its own immune cells, is there still a
need for the systemic immune response, not only in inﬂamma-
tory or traumatic conditions but also in homeostasis? Are we
starting to question the notion of the brain as an “immune priv-
ileged site” ﬂanked by high walls? On the contrary, the intensive
research made by the groups working together at these brain barri-
ers have delimited the potential gates for leukocyte entrance as well
as the spatial and temporal requirements that could allow them
to pass through without compromising its integrity (Interlandi,
2013).
Each tissue of the body has its own specialized immune cells
adapted to ﬁght their common pathogens without the wise of
general immunity. Nevertheless, when an important insult is
threatening our integrity as a whole both, general immunity and
brain innate immunity have to cooperate in close to restore body
homeostasis. Thus, if an inﬂammatory process affects the body,
primed T cells secrete cytokines that indeed reach the CNS. It is
from there, that an innate brain immune response is generated to
control the body response during the particular insult.
For example, when we have fever, symptoms as loss of appetite,
arousal, blushing, or somnolence are part of this innate brain
response to interleukin-1 and other T-cytokines triggered in
response to the infection (Steinman, 2012). Therefore, there is
increasing evidence that in both, homeostatic and inﬂammatory
conditions, an active dialog exist between the brain and the body.
Thanks to the great efforts made by neuroimmunologists in the
last 20 years now we know that this relationship is bidirectional:
neurons embracing immune cells directly in peripheral tissues
have been photographed and also blood-derived leukocytes are
found across the barriers in healthy subjects.
This review intends to focus the attention into the routes that
allow peripheral monocytes to enter and differentiate inside brain
barriers and their potential function in health and neuroinﬂam-
mation.
POTENTIAL GATES FOR MONOCYTE ACCESSING TO THE
BRAIN
Research made in the last 10 years about the structure and cellular
interplay at the blood–brain barrier (BBB) has gifted us with a
new vision about the routes that leukocytes can use to cross them,
even in homeostatic conditions. Indeed, experts in the ﬁeld agree
in considering that the concept of immune privilege has to be
reinterpreted in the CNS. Ehrlich’ description and demonstration
of limited frontiers for molecules do not apply in the same way to
cells (Wilson et al., 2010; Dyrna et al., 2013). Therefore, to better
understand how monocytes can be found inside the barriers it
could be helpful to brieﬂy describe the potential gates for them to
access.
To start checking the routes for entrance of blood-derived
macrophages to the CNS is important to remember that meninges,
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that separate the skull to the brain parenchyma, are composed of
three membranes; the outer membrane – the dura mater, the mid-
dle membrane – the arachnoid – and the inner membrane – the
pia matter – that surround the neuropil. All these membranes are
encompassed by a BBB in which the structure of the blood ves-
sels has huge differences on distinct and well deﬁned sections of
the vascular tree. Blood ﬁrst ﬂow through the pia mater and then
is poured into the subarachnoid space where the Virchow–Robin
space is formed. Blood supply to the brain enters through four
arteries, the internal carotid arteries and the vertebral arteries,
which merge in the circle of Willis at the base of the brain. There-
after, they are branched in arterioles and capillaries that irrigate all
the CNS parenchyma (Wilson et al., 2010).
THE BBB
The BBB comprises the capillary and postcapillary vessels at the
brain and spinal cord (SC). According to its architecture but also
its functionality is built up by neuro (glio) vascular units (NVU;
Ballabh et al., 2003; Hawkins and Davis, 2005), and has huge dif-
ferences depending on their particular location along the brain
and SC. The ﬁrst cellular component that separate the CNS from
circulation is the brain endothelium in which cells are attached by
tight junctions (TJs) and adherent junctions (AJs) (Lampron et al.,
2013).
A more detailed look into the structure of the barriers have
shown that recognizing the differences in the gage of vascular
tree between capillary versus postcapillary vessels is key to under-
stand why there are a limited number of portals for leukocyte
recruitment:
Neuro vascular units at capillaries are composed of brain
endothelial cells – with special T and J junctions – and surrounded
by pericytes. There is only one basement membrane between
endothelial cells and the astrocyte endfeet of the glia limitans.
Therefore, the pass through this capillary barrier requires a very
precise regulation. Perhaps this could be the most difﬁcult pas-
sage, but even at capillaries is possible for blood cells to cross
through two adjacent NVUs and thus avoid the endothelial junc-
tions, as suggested by some authors (Carson et al., 2006; Dyrna
et al., 2013).
Neuro vascular units in pre and post-capillary vessels, as well as
in arterioles, has, however; an important difference: the astrocyte
endfeets are not in intimal contact with the endothelial layer but
separated from thembypericytes and smoothmuscle cells forming
the media and also by a key perivascular space, named in humans
the Virchow–Robin space. The differences in biochemical compo-
sition of the vascular and glia basement membranes may explain
why leukocytes under normal conditions could pass the former
but not the latter and thus, they are found mostly trapped in the
middle (Bechmann et al., 2007) but actively patrolling between
frontiers, perhaps in an intermediate differentiation state.
MACROPHAGE RECRUITMENT ACROSS THE BBB
The ﬁrst and key unresolved question that deserves discussion is
why blood-derived macrophages are needed inside the CNS hav-
ing the brain its own innate immune macrophages, the microglial
cells. Therefore, many authors have tried to investigate whether
macrophages and microglia have differential speciﬁc roles or
rather their functions could be considered redundant. As adult
microglia derive of an embryonic population of myeloid cells
that migrated into the brain during mammalian embryogenesis
(Cuadros and Navascués, 1998; Ginhoux et al., 2010), it is clear
now that blood-derived macrophages are not the same cells as
microglia, although sharing many membrane determinants and
having conserved the general features of phagocytic cells. Indeed,
all resident tissue macrophages have their own genetic program
adapted and triggered by the innate and metabolic features of
their particular tissue (Gundra et al., 2014). Thus, blood-derived
macrophages must be recruited to exhibit their alternate roles as
will be discussed.
Monocyte recruitment across the BBB according with the
last ﬁndings would occur mostly at the level of post-capillary
venules. In fact, two different steps have been proposed for them
to gain access to the inner brain: ﬁrst they must transmigrate
from the endothelial wall to perivascular spaces and then, in a
separate temporal sequence, they could progress across the glia
limitans into the parenchyma (Owens et al., 2008). The demon-
stration that there is a population of perivascular macrophages
being regularly renewed by the blood in the absence of pathol-
ogy came from studies of bone marrow chimeras. Bechmann
et al. (2001) used transplants of green-ﬂuorescent-protein (GFP)-
transfected bone marrow cells to clearly show that as soon as
2 weeks after transplant there was a replacement of perivascu-
lar cells by blood-borne macrophages in adult mice. These results
were the ﬁrst to prove that brain perivascular cells were not res-
ident histiocytes but blood-derived macrophages. However, at
this level of the BBB, even in postcapillary vessels, the migra-
tion of macrophages and T cells into the brain parenchyma have
been proved to occur only under inﬂammatory conditions, as
extensively reviewed by others (Engelhardt and Ransohoff, 2012;
Lampron et al., 2013). Therefore, in healthy brains the role of
perivascular macrophages could be to stay on hold living between
barriers, but with a very noble function; to sense changes in
immunity from inside to outside and proﬁling their differentiation
programs accordingly.
THE BLOOD–CEREBROSPINAL FLUID (CSF) BARRIER
This barrier is present at the lateral ventricules and has two main
differences with the BBB:
First, the capillaries that form the choroidplexus (CP) are fenes-
trated, with little holes like a fenestra, enough to allow the entrance
of molecules bigger than 500 D, the limit estimated for molecules
that can cross an intact BBB.
Second, the cellular epithelium that produce the CSF down the
subarachnoid space, have lateral junctions but they are not as tight
as those of the endothelial cells within the BBB. In fact, there is
a consensus in assigning the CP of the ventricular system as the
main route for the entrance of central immune cells into the CNS
(Wilson et al., 2010). There, specialized epithelial cells (Kolmer
cells) make the CSF and drop it in the subarachnoid space. Below
the epithelium lay the fenestrated endothelium separated by the
basal membrane of the internal meninge, the Pia matter.
Systemic monocytes within the CSF are recruited by adhesion
molecules and chemokines expressed by capillary endothelial cells
at these places that also allow the crossing of T cells. Otherwise,
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they continue traveling, ﬂoating and circulating within the CSF
from the meninges toward the CNS and then back to bath all
the SC. Normally, there is from 100 to 150 ml of CSF always in
circulation that is ﬁnally reabsorbed in the arachnoid villies, at
the superior central sinus, by hydrostatic forces (Ransohoff and
Engelhardt, 2012).
Recently, (Iliff et al., 2012) by using in vivo two-photon imaging
techniques have demonstrated that a substantial amount of sub-
arachnoid CSF cycles through the brain parenchyma: CSF enters
the parenchyma through perivascular spaces that surround pene-
trating arteries, is exchanged with the brain interstitial ﬂuid and
ﬁnally cleared along perivenous drainage. They have termed this
pathway as “the glymphatic system” because is supported by the
water transport system of astrocytes.
The demonstration of this route suggest that immune cells of
CSF could have direct contact with extracellular brain proteins and
solutes and therefore participate in its clearance or alternatively
start to mount an effective immune response.
MACROPHAGE RECRUITMENT ACROSS THE CHOROID PLEXUS
There is a consensus in assigning the CP as the most accessible
yet selective gate for leukocyte transmigration into the brain. The
cellular composition of ventricular and lumbar CSF differs from
that of the blood and is dominated by CD4+memory T cells and
macrophages (Matyszak et al., 1992; Ransohoff et al., 2003).
It has been demonstrated that CP constitutively expresses adhe-
sion molecules and chemokines which support trans-epithelial
leukocyte trafﬁcking (Steffen et al., 1996). The research to ﬁnd
the most suitable candidates for cell recruitment has been very
intensive. Even in absence of ongoing inﬂammation macrophages
are able to cross the CP. Therefore, adhesion molecules that
could facilitate its entry to the inner brain space have been
checked ﬁrst between those expressed constitutively by the CP
epithelium. These include P-selectine, VCAM 1 as in vascular
endothelium, or the integrin receptor ICAM 1 which is local-
ized on the apical side of the CP and suggested as a gate for
“basal to apical” migration (Kunis et al., 2013). In addition,
macrophages would need to be attracted by chemokines such as
CCL19 and CCL20 that are constitutive in Kolmer cells (Krumb-
holz et al., 2007). All these results suggest that trafﬁcking trough
the CP appears to be controlled by the epithelium. Moreover, a
unique feature of the CP is the presence of a large population
of macrophages and dendritic cells within the stroma, implying
that this compartment may provide an important source of these
cells traveling along cerebral ventricles as shown by Meeker et al.
(2012).
One of the ﬁrst pioneering researches about the multiple
roles of macrophages in CNS injury has been performed by the
group of Michal Schwartz. They have demonstrated that after SC
injury, blood-derived macrophages are recruited from the dis-
tant CP with a clear reparative function. The authors also show
that macrophage recruitment to an injured SC came from two
different places: the adjacent leptomeninges allowed the inﬁltra-
tion of classically activated (M1) macrophages that were involved
in an effective inﬂammatory response, while a second remote
gate through the CP allowed the entry and differentiation of
macrophages that expressed a reparative (M2) phenotype. These
elegant experiments suggest that in response to parenchymal dam-
age, peripheral immune cells go through this route, which are also
followed by T cells and even neutrophils in the context of sustained
inﬂammation (Shechter et al., 2013b). Their results are supported
by the evidence that in homeostasis, the phenotype of the CSF in
which they patrol is immunosuppressive, having an enrichment
of anti-inﬂammatory cytokines such as IL-13 and TGF-β, as also
occurs in other immune privileged tissues (Schwartz and Baruch,
2014).
THE BLOOD–SPINAL CORD BARRIER
At this level theNVU includes endothelial cells that are surrounded
by pericytes and astrocytes but the extracellular matrix has several
intrinsic features. There is not CP because of the occurrence of
nerve root entry zones in the transition to the peripheral nervous
system. Therefore, the permeability of this BBB is higher than in
other areas of thebrain. On theotherhand, theCSF contacts the SC
at two places: the spinal subarachnoid space with leptomeninges
as the interface layer and the central canal with the ependymal
layer. The cellular composition of this NVU contains less pericytes
surrounding endothelial cells. This has been proposed as the rea-
son for the increased permeability of this barrier (Winkler et al.,
2012).
There are many examples of leukocyte extravasation in SC
injury or autoimmunity. However, there is little information about
the gates of entry for them in homeostatic conditions. Schnell et al.
(1999), compared the response to injury between the brain and SC
in mice and found that in the SC, there was higher numbers of cells
recruited at the lesion site that reached easily the parenchyma,
suggesting that the BBB at this location is provided with addi-
tional gates for macrophage recruitment, perhaps due to the CSF
circulation.
MACROPHAGE RECRUITMENT ACROSS THE BLOOD–SPINAL CORD
BARRIER
Due to the technical difﬁculty of clearly differentiate resident
microglia from blood-derived macrophages after a traumatic or
autoimmune disorder, there is still some controversy about the
role of each one during pathology. Recently, Greenhalgh and
David (2014) by using a mouse model in which macrophages
could be distinguished from microglia have shown that microglial
cells are the ﬁrst responders (within minutes) to tissue destruction
and exhibit higher efﬁciency in removing debris than recruited
macrophages. Noteworthy, this work also points to an effective
and necessary recruitment of blood-derived cells to help with tis-
sue reparation. For this reason, researches are starting thinking
that the clue must be to maintain the proper balance and action
time in which classic versus alternative response of macrophages
are triggered.
On the other hand, during the preparation of this review,
Carrillo-Salinas et al. (2014) have demonstrated that a phyto-
cannabinoid derivative was able to switch T cell and macrophage
inﬂammatory phenotypes in vivo; inhibiting Th1 and Th17 acti-
vation at the SC of experimental autoimmune encephalomyelitis
(EAE) treated animals. Furthermore, they show that this com-
pound is a potent activator of PPAR-γ receptors, which in
turn are potent modulators of macrophage alternative programs
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(Gallardo-Soler et al., 2008). Therefore, appears to be clear that
molecules able to trigger reparative and regenerative programs to
change macrophage activation could be of potential therapeutic
interest for brain pathologies cursing with inﬂammation.
THE BLOOD–RETINA BARRIER (BRB)
The inner part of this barrier is formed by endothelial cells of
retina capillaries and contains the same structural components
within the NVU. The outer barrier is made by the retinal pig-
ment epithelium. Regarding permeability properties, this barrier
enables greater penetration of hydrophilic compounds.
Althoughmuch less studied, there is increasing interest in deﬁn-
ing the potential gates for the entry of blood-derived cells into
retina. Shechter et al. (2013a) have pointed to epithelial retinal
cells as the interface in which takes place the intraocular migration
of leukocytes, which is also favored by the fenestrated epithelium
of the ciliary body (Lightman and Greenwood, 1996).
MACROPHAGE RECRUITMENT ALONG THE BRB
The permissibility of epithelium pigmentosum for blood cells has
been demonstrated in models of uveitis and retinal lesions (Joly
et al., 2009) and there is agreement in accepting that both, retinal
pigment epithelium and ciliary body epithelium have immuno-
suppressive properties, pointing to a major role of these eye
interfaces as the place for selective cell recruitment. Regulatory T
cells and reparativeM2macrophages have been shown to be essen-
tial in resolving inﬂammation in experimental uveitis, as reviewed
by Kerr et al. (2008). Being the eyes the soul of the brain (Perez
et al., 2013) it would be desirable to gain a deeper knowledge on
the role of macrophages at this important barrier.
A brief summary of macrophage locationwithin themain brain
barriers is presented in Table 1, in which each reference is just an
example in which blood-derived macrophages have been found
at these brain interfaces either in healthy or inﬂammatory neuro-
logical conditions. It is also important to note that blood-derived
cellular transmigration, at least in the ﬁrst stages of neuroinﬂam-
mation, does not necessary imply the breach of the brain barriers
that often while require a temporal and chronic cellular invasion
as occur in non-resolving neurological diseases but also obviously,
after a serious insult such are brain injury or stroke, when the brain
immune surveillance is lost.
THE MANY FACES OF MACROPHAGE ACTIVATION IN BRAIN
INNATE IMMUNITY
Macrophages are very heterogeneous populations of cells that have
evolved epigenetically different within each tissue of the body.
Therefore, although conserving its common CD markers, kupffer
cells, alveolar macrophages, or microglia have its own particular
program adapted to preserve the innate immune functions in both
homeostatic and inﬂammatory conditions.
The CNS also has its own immune population, the microglia,
recently shown to migrate from theYolk Sac and colonize the brain
parenchyma during embryogenesis, before the brain barriers are
formed. In contrast, peripheral macrophages that enter the brain
derive from circulating Ly6Chi monocytes originated from bone
marrow hematopoietic stem cells in a Myb-dependent manner
(Schulz et al., 2012).
Moreover, these two populations remain distinct as it has been
demonstrated by Ajami et al. (2011) in a model of EAE. Therefore,
monocytes that cross brain borders are transformed into diverse
cell populations able to acquire multiple effector functions always
depending on the balance between the innate and the adaptive
modes of immune response.
However, there is still some consensus in assuming that any
cellular extravasation from blood to brain is or will be harmful
and detrimental, especially macrophages, because they have been
indeed found in all brain inﬂammatory diseases. The consequence
of this idea has been the basis of generalized prescription of corti-
coids for nearly all autoimmune diseases. These protocols are still
being applied.
CLASSIC VERSUS ALTERNATIVE MACROPHAGE ACTIVATION
The concept of macrophage alternative activation started 20 years
ago when several groups were interested in understanding the
response of antigen presenting cells (APCs) to Th2-derived
cytokines (Stein et al., 1992). Independently, our group started to
study themetabolic fate of L-argininemetabolism inmacrophages.
We found that inductors of nitric oxide synthase II (NOS II)
Table 1 | Monocyte recruitment through intacts brain barriers.
Barriers Macrophage locations CNS status References
Brain endothelium(BBB) -Perivascular macrophages at postcapillary levels
-Recruited and crossing through capillary endothelium
-Homeostasis
Neuroinﬂammation
Bechmann et al. (2007)
Owens et al. (2008)
Choroid plexus(B-SCFB) -Macrophages in choroid plexus stroma
-Monocyte/macrophage in CSF (25% in humans)




Matyszak et al. (1992)
Meeker et al. (2012)
Ransohoff and Engelhardt (2012)




Bartholomäus et al. (2009)
Shechter et al. (2013a)
Spinal cord(B-SCB) -Macrophages recruitment from CSF
-M2-activated macrophages from CPt
Neuroinﬂammation
Response to injury
Winkler et al. (2012)
Schwartz and Baruch (2014)




Kerr et al. (2008)
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such Th1-derived cytokines, catabolized L-arginine to NO, and
citrulline. Conversely, when cells were triggered with Th2-derived
cytokines, such as IL-4, IL-10, or IL-13 (known to suppress iNOS
expression) they switched their metabolic state to express arginase
I and generated urea and ornithine (Corraliza et al., 1995). There-
fore,macrophageswere notdeactivated by these anti-inﬂammatory
cytokines, but acquired an alternative pattern of genes involved in
tissue repair and remodeling (Munder et al., 1998). Subsequently,
other workers introduced the terms of M1 and M2 to mimic the
models of macrophage activation with those of T cell polarization.
However, M1 and M2 cells, are only present in pathological
conditions and represent two extreme opposites stages, nearly the-
oretical, among the plethora of patterns in which cells respond
to homeostasis and inﬂammation, as reviewed by Gordon and
Martinez (2010).
Noteworthy, the characterization of macrophage phenotypes
have moved a lot further to recognize several populations on the
basis of their molecular markers; the M1 classical activated pheno-
type is triggered by IFN-γ or LPS, or combinations of Th1-derived
cytokines, but also by a great plethora of CD markers and medi-
ators. M2-like macrophages are, in turn, a heterogeneous cell
population in which different subtypes are being continuously
emerging. In agreement with Martinez and Gordon (2014), these
phenotypes have to be revisited, taking into account the times and
places in which they are expressed.
PHENOTYPES AND ROLES OF BRAIN-RECRUITED MACROPHAGES
Brain resident macrophages do exist within the brain. They are
betweenbarriers as perivascularmacrophages,meningeal and ven-
tricular macrophages or macrophages that circulate within the
CSF. Therefore, although there is still the idea of connecting cell
recruitment with brain inﬂammation, macrophages must achieve
other important roles in homeostasis such as the recognition of
CNS-speciﬁc antigens as well as fagocytosis of cellular debris at
places where microglia is not accessible. In fact, not only sys-
temic macrophages go to the CNS in brain diseases but they are
also found transmigrated through the CSF in basal ganglia, hip-
pocampus and motor cortex, perivascular spaces, after liver injury
(D’Mello et al., 2009), where they account for the alterations in
neural transmission that occurs when the homeostasis of the body
is lost.
Examples about the role of reparativemacrophages in SC injury
have been beautifully demonstrated and reviewed by Schwarch’s
group, which have made important contributions in the ﬁeld of
macrophage biology at brain borders. They also have highlighted
the importance in discerning between the routes and pheno-
type markers of blood-derived monocytes for the resolution of
CNS-affecting diseases (Shechter et al., 2013a) and propose the
distinction between “educational gates,” in which blood cells will
acquire the correct phenotype, either inﬂammatory or repara-
tive, and“absolute barriers,” in which macrophages entrance could
perhaps compromise the integrity of the BBB.
In independent experiments, it has been also shown the
potential of blood monocytes in actively regenerating myelin in
injured brain. Miron et al. (2013) showed that both M1 and
M2-like macrophages were recruited for remyelination, but a
critical switch to an M2-like state was necessary during the
regenerative process. Accordingly, Jeong et al. (2013) showed that
the recovery of myelin was clearly dependent on macrophage
intervention and recalled the potential beneﬁcial effects of a pro-
tective brain inﬂammation. Transient and not chronic must be
the clue, because during the resolution from injury, microglia
must return to a resting state and, as experimentally assessed by
several authors, circulatory macrophages are “vanished” (Ajami
et al., 2011). In agreement with this, Bellavance et al. (2014) have
shown that recruitment of circulating PU.1-expressing cells dur-
ing excitotoxicity is neuroprotective. More importantly, these
macrophages that released neurotrophic factors also“disappeared”
upon recovery, pointing again to a transient but essential role
for macrophages in their experimental conditions. In line with
this, research in a mouse model of Alzheimer disease also has
shown that monocytes were crawling onto the luminal walls of Aβ
venules to efﬁciently clear amyloid beta protein (Lampron et al.,
2013).
Macrophage effector roles within the brain also affect brain
tumors. Recently, Pyonteck et al. (2013), demonstrated that in a
mouse model of glioblastoma, when they used a CSF-1 inhibitor
to target tumor associated macrophages (TAM) surprisingly, cells
were re-educated to change the tumor-induced M2 phenotype, in
which arginase I was protumorigenic, toward a M1 anti-tumor
phenotype maintained by GM-CSF and IFN-γ secreted by the
tumor with the potential to actively kill glioma cells.
All these results strongly suggest that blood-derived
macrophages can reach nearly every region within the brain, if
they are driven and attracted to found the correct gates.
The impressive recent development of in vivo imaging tech-
niques, together with the generation of new mouse models, open
new opportunities to search for the location, properties and
dynamics of these inﬁltrated macrophages and their participation
in brain immunity.
Finally, it is worthy to mention the results shown by the Ned-
ergaard’s group (Iliff et al., 2012) which demonstrated that a
substantial portion of subarachnoid CSF cycles through the brain
interstitial space. By ﬂuorescent-labeling of protein beta amyloid,
they showed that its clearance was dependent on the expression
of the water channel aquaporin-4 (AQP4) present in astrocytes,
because the ﬂux was markedly reduced in mice lacking the water
channel. This transport system, CSF-dependent raises the possi-
bility that macrophages at this location along with perivascular
macrophages (Thanopoulou et al., 2010) could contribute to the
clearance of Aβ protein by SR-BI, scavenger receptors.
CONCLUDING REMARKS
The huge efforts made by neuroscientists to elucidate the struc-
tural and cellular components of the different blood–CNS barriers
have been essential to understand the complex interplay between
the body and brain modes of immunity. In parallel, basic immu-
nologists have changed completely the view of innate immunity
recognizing thatmacrophages are not resting cells livingwithin tis-
sues to engulf foreign material; neither are they ringleaders in the
process of chronic inﬂammation or tissue degeneration. On the
contrary,macrophage plasticity and heterogeneity havemade us to
revise their putative functions in each tissue both, in homeostasis
and in disease conditions.
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The existence of a resident population of macrophages born,
grown and matured along the embryonic development of mam-
malian brain, the microglial cells, suggest that the main roles of
these macrophages are directly related with brain homeostasis,
together with astrocytes. However, it is now clear that the brain
have also other population of macrophages living in perivascular
spaces, as well as other specialized cell populations sharing features
of APCs such as pericytes at the NVUs or stromal cells integrated
within the epithelial barriers. Thus, the concept of the brain as an
immune privileged place could be reinterpreted as a territory with
a double and cooperative immunity:
From the inside, the main role of microglial cells could be
to control inﬂammation due to neuronal degeneration, CNS-
speciﬁc antigen recognition and perhaps the most important one:
to coordinate the brain response to peripheral diseases through
the constant dialog with T cells and its mediators.
From the outside, naïve myeloid precursors must be neces-
sary in the context of brain inﬂammation, injury, or infection in
which, as in other body tissue, the general immune system must
be recruited.
Inﬂammation is never the direct cause of a disease but the
consequence of a healthy immune systemable to efﬁciently remove
cellular death, limit growth deregulation or ﬁght against pathogen
invasion and have a second reparative-healing role, essential to
restore tissue homeostasis.
In conclusion, in light of the promising results obtained in ani-
mal models, it can be anticipated an increase of research focused
in the characterization of human CD markers, able to distingue
resident microglia and macrophage populations within barriers,
a prerequisite to design new therapies adapted to human brain
diseases.
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